ATE550073T1 - Protein c für die wundheilung - Google Patents

Protein c für die wundheilung

Info

Publication number
ATE550073T1
ATE550073T1 AT02729651T AT02729651T ATE550073T1 AT E550073 T1 ATE550073 T1 AT E550073T1 AT 02729651 T AT02729651 T AT 02729651T AT 02729651 T AT02729651 T AT 02729651T AT E550073 T1 ATE550073 T1 AT E550073T1
Authority
AT
Austria
Prior art keywords
protein
apc
wound healing
agent
medicament
Prior art date
Application number
AT02729651T
Other languages
German (de)
English (en)
Inventor
Christopher Jackson
Philip Sambrook
Original Assignee
Univ Sydney
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPR5637A external-priority patent/AUPR563701A0/en
Priority claimed from AUPS1433A external-priority patent/AUPS143302A0/en
Application filed by Univ Sydney filed Critical Univ Sydney
Application granted granted Critical
Publication of ATE550073T1 publication Critical patent/ATE550073T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4866—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02729651T 2001-06-13 2002-06-11 Protein c für die wundheilung ATE550073T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPR5637A AUPR563701A0 (en) 2001-06-13 2001-06-13 Treatment and composition for wound healing
AUPS1433A AUPS143302A0 (en) 2002-04-02 2002-04-02 Treatment and composition for wound healing
PCT/AU2002/000751 WO2002100445A1 (en) 2001-06-13 2002-06-11 Treatment and composition for wound healing

Publications (1)

Publication Number Publication Date
ATE550073T1 true ATE550073T1 (de) 2012-04-15

Family

ID=25646727

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02729651T ATE550073T1 (de) 2001-06-13 2002-06-11 Protein c für die wundheilung

Country Status (8)

Country Link
US (3) US20040176288A1 (enExample)
EP (1) EP1404412B1 (enExample)
JP (1) JP4351041B2 (enExample)
AT (1) ATE550073T1 (enExample)
AU (1) AU2002302192B2 (enExample)
CA (1) CA2450240A1 (enExample)
ES (1) ES2384099T3 (enExample)
WO (1) WO2002100445A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2298338T1 (sl) 2002-09-16 2012-11-30 Agennix Inc Laktoferinski sestavki in postopki za zdravljenjekožnih ran
US7183381B2 (en) 2004-10-26 2007-02-27 Agennix, Inc. Composition of lactoferrin related peptides and uses thereof
US20080293631A1 (en) * 2005-01-07 2008-11-27 Christopher John Jackson Treatment for Autoimmune and Inflammatory Conditions
DK1853631T3 (en) * 2005-01-24 2016-03-29 Univ Texas Fc-FUSION CONSTRUCTIONS BINDING TO PHOSPHATIDYLSERINE AND THERAPEUTIC APPLICATION THEREOF
BRPI0613227A2 (pt) * 2005-06-09 2011-01-04 Chiang Chuan Chi uma composição para cicatrização de ferida e uso desta
WO2007075853A2 (en) * 2005-12-20 2007-07-05 Swiss-American Products, Inc. Protease compositions for the treatment of damaged tissue
GR1005700B (el) * 2006-09-01 2007-10-22 (40%) ����� �������� Τροπος αντιμετωπισης της 1ης φασης του εγκαυματοσσε μη σηπτικους ασθενεις με συνεχη ενδοφλεβια χορηγηση ενεργοποιημενης πρωτεινης-c για 48 ωρες με στοχο τη μειωση της τελικης εγκαυματικης βλαβης καιαυξηση της ταχυτητας επουλωσης κατα τα πρωτα επτα μετεγκαυματικα 24ωρα
AR067345A1 (es) * 2007-07-10 2009-10-07 Paion Deutschland Gmbh Uso de trombomodulina para la preparacion de un medicamento trombolitico
EP2014296A1 (en) * 2007-07-10 2009-01-14 PAION Deutschland GmbH Novel strategies for increasing the reperfusion in obstructed blood vessel
GB2457965B8 (en) * 2008-07-01 2011-02-16 Renovo Ltd Methods and systems for determining efficacy of medicaments.
US20130259854A1 (en) * 2012-04-02 2013-10-03 Saint Louis University, A Non-Profit Organization Methods and compositions for reducing the incidence of post-surgical adhesions
CN104394883B (zh) * 2012-07-04 2017-05-31 悉尼大学 炎性皮肤病症的治疗
EP3137102B1 (en) * 2014-04-16 2021-07-14 ZZ Biotech LLC Apc for use in the treatment of abnormal cutaneous scarring
US20170035862A1 (en) * 2014-04-16 2017-02-09 Zz Biotech Llc Use of APC analogue for wound healing
TR202021285A1 (tr) * 2020-12-22 2022-07-21 Univ Yeditepe Yara skarinin önlenmesi̇ ve tedavi̇si̇nde kullanilmak üzere erbium borat i̇çeren formülasyon

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571786A (en) * 1990-08-16 1996-11-05 Immuno Aktiengesellschaft Use of protein C or the activation peptide of protein C for preparing a pharmaceutical preparation
US6197325B1 (en) * 1990-11-27 2001-03-06 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US5648380A (en) * 1991-03-01 1997-07-15 Warner-Lambert Company Anti-inflammatory wound healing compositions and methods for preparing and using same
AT397615B (de) 1991-05-14 1994-05-25 Immuno Ag Arzneimittel enthaltend protein c
US5279956A (en) * 1991-06-24 1994-01-18 The Scripps Research Institute Activated protein C polypeptides and anti-peptide antibodies, diagnostic methods and systems for inhibiting activated protein C
EP0651655A4 (en) * 1992-07-24 1996-05-29 Oklahoma Med Res Found REDUCTION OF MICROVASCULAR BLEEDING DURING SURGERY BY BLOCKING PROTEIN C ACTIVATION
US5583102A (en) * 1993-12-03 1996-12-10 University Of Iowa Research Foundation Human thrombomodulin in wound healing
AU2467395A (en) * 1994-05-04 1995-11-29 Board Of Trustees Of The University Of Arkansas, The Novel ophthalmologic uses of protein c
JP3802104B2 (ja) 1995-05-31 2006-07-26 財団法人化学及血清療法研究所 脊髄損傷に伴う神経障害の予防・治療剤
SE9600216D0 (sv) * 1996-01-18 1996-01-18 Hans Arne Hansson Styrning av läkningsprocesser
HUP0001237A3 (en) * 1997-10-20 2002-01-28 Lilly Co Eli Methods for treating vascular disorders
JP3578627B2 (ja) * 1998-05-15 2004-10-20 株式会社ホギメディカル 創傷患部の治癒を促進する組織シーラント
CA2358492A1 (en) 1998-12-21 2000-06-29 Eli Lilly And Company Combination therapy for the treatment of sepsis
WO2001056532A2 (en) 2000-02-04 2001-08-09 The Scripps Research Institute Neuroprotective, antithrombotic and anti-inflammatory uses of activated protein c (apc)
ES2242740T3 (es) * 2000-03-28 2005-11-16 Eli Lilly And Company Proteina c activada para el tratamiento de pancreatitis.
US7204981B2 (en) * 2000-03-28 2007-04-17 Eli Lilly And Company Methods of treating diseases with activated protein C

Also Published As

Publication number Publication date
EP1404412A1 (en) 2004-04-07
US8728512B2 (en) 2014-05-20
CA2450240A1 (en) 2002-12-19
EP1404412A4 (en) 2006-03-01
EP1404412B1 (en) 2012-03-21
US20040176288A1 (en) 2004-09-09
US20140219991A1 (en) 2014-08-07
ES2384099T3 (es) 2012-06-29
JP2004532892A (ja) 2004-10-28
AU2002302192B2 (en) 2007-08-16
US20130280234A1 (en) 2013-10-24
WO2002100445A1 (en) 2002-12-19
JP4351041B2 (ja) 2009-10-28
WO2002100445A8 (en) 2006-10-26

Similar Documents

Publication Publication Date Title
ATE550073T1 (de) Protein c für die wundheilung
NO20040319L (no) Sårforbinding, fremgangsmåte for fremstilling av et preparat, topisk farmasøytisk avgivelsessystem samt applikator
DE60138549D1 (de) Topische gel-abgabesysteme zur behandlung von hauterkrankungen
DE60107819D1 (de) Verabreichungssystem für topische hautpflegemittel
DE69734661D1 (de) Foerderung der wundheilung durch chemisch modifizierte tetracycline
DE60212163D1 (de) Kontrolliertes wirkstoffabgabesystem
EE05419B1 (et) Asendatud oksasolidinoonid kombineeritud raviks
SE9701162D0 (sv) New use II
ATE336233T1 (de) Membranverabreichungssystem für wirkstoffe
ATE292481T1 (de) Verbesserte wundauflagen
PL370310A1 (en) Method of improving the growth performance of an animal
AU2001246484A1 (en) Anti-infective active substance combinations and the use thereof for the topical treatment of fungus diseases of toe and finger nails
CA2473760A1 (en) Topical ivermectin composition
PT1361903E (pt) Penso para feridas
ATE339224T1 (de) Honig enthaltende pharmazeutische zusammensetzung zur wundbehandlung
DE60233891D1 (de) Selektives targeting von apoptotischen zellen
ATE410195T1 (de) Hydrokolloidzusammensetzungen
ATE241338T1 (de) Arzneistoffabgabesystem, insbesondere zur verabreichung von androgenen
DE60142632D1 (de) Heilung von wunden
JP2004532892A5 (enExample)
ATE369880T1 (de) Mediziniscer verband
ES2174533T3 (es) Uso de una mezcla de un diol y un acido alfa-hidroxi para el tratamiento de enfermedades de la piel hiperqueratoticas.
BR0213183A (pt) Uso de ativadores gp130 em neuropatia diabética
NO20031650D0 (no) Nye legemidler for leversykdommer
BR0109896A (pt) Composição tópica em gel, curativo de feridas, seu método e uso